Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.34%
1,089.54
+3.73
+0.34%
—1,085.811,083.231,092.001,074.08——
SIXC
Communications
SIXC
Communications
SIXC
+0.32%
609.66
+1.97
+0.32%
—607.69607.69610.58604.02——
SIXE
Energy
SIXE
Energy
SIXE
-0.08%
1,191.43
-0.95
-0.08%
—1,192.381,200.061,206.851,186.65——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.27%
1,751.64
-4.75
-0.27%
—1,756.391,753.531,760.321,733.52——
SIXM
Financials
SIXM
Financials
SIXM
-0.28%
631.47
-1.80
-0.28%
—633.27631.36633.90628.75——
SIXR
Staples
SIXR
Staples
SIXR
-0.18%
850.90
-1.52
-0.18%
—852.42853.25856.20850.67——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.47%
217.76
-1.03
-0.47%
—218.79218.79219.49217.26——
SIXT
Technology
SIXT
Technology
SIXT
+1.36%
3,761.99
+50.30
+1.36%
—3,711.693,719.293,776.213,699.88——
SIXU
Utilities
SIXU
Utilities
SIXU
-1.13%
900.79
-10.26
-1.13%
—911.05909.99913.34900.08——
SIXV
Health care
SIXV
Health care
SIXV
+1.41%
1,521.84
+21.18
+1.41%
—1,500.661,504.161,526.631,504.16——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.47%
2,466.62
+11.66
+0.47%
—2,454.962,450.632,468.772,435.72——
SABSW:NASDAQ
SAB Biotherapeutics
$0.016
0.00%
(0.00) 1D
May 22, 11:57:37 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SABSW...
Mkt. cap
272.98M
Avg. vol.
17.30K
Volume
0.00
52-wk high
$0.14
52-wk low
$0.02
Beta
0.83
No. of employees
86
News stories
From sources across the web
About SAB Biotherapeutics
CEO-
Employees86
Founded2014
HeadquartersMiami Beach, Florida, United States
SectorBiotechnology
Websitesab.bio
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
7.00M
8.97M
9.73M
-
Cost of revenue
7.00M
8.97M
9.73M
-
Research and development expenses
-
-
-
13.40M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.74M
3.71M
6.04M
6.60M
Operating expense
2.74M
3.71M
6.04M
20.00M
Total operating expenses
9.73M
12.68M
15.77M
20.00M
Operating income
-9.73M
-12.68M
-15.77M
-20.00M
Other non operating income
-331.43K
57.51M
-1.73M
144.40K
EBT including unusual items
-10.11M
45.45M
-16.86M
-18.87M
EBT excluding unusual items
-10.11M
45.45M
-16.86M
-18.87M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-10.11M
45.45M
-16.86M
-18.87M
Net profit margin
-
-
-
-
Earnings per share
-
-
-0.41
-
Interest and investment income
13.56K
655.23K
700.74K
1.05M
Interest expense
-64.34K
-43.29K
-63.46K
-62.74K
Net interest expenses
-50.78K
611.94K
637.28K
984.45K
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.96M
-11.91M
-15.01M
-19.25M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer